Anticytokine Autoantibodies: Association with Infection and Immune Dysregulation
AbstractThe association of autoantibodies to cytokines with immune deficiency, autoimmunity and/or immune dysregulation is increasingly being recognized. For example, autoantibodies to interferon gamma have been found to be associated with chronic, treatment refractory infections with intracellular organisms such as mycobacteria, autoantibodies to interleukin 17 with chronic mucocutaneous candidiasis, and anti-interferon alpha autoantibodies with systemic lupus erythematosus. While low titer autoantibodies to these and other cytokines may be detected in normal individuals, patients with infectious or autoimmune manifestations tend to have high titer autoantibodies that may block or potentiate the function of the respective cytokine. Recognition of these autoantibodies is important because it may direct treatment toward a combination of adjunctive immunotherapy to modulate the autoantibody level while continuing with appropriate anti-microbial therapy. This review focuses on the anti-cytokine autoantibodies documented to date, their autoimmune, immune dysregulation and infectious disease associations, methods for detection of these antibodies and potential treatment options. View Full-Text
Share & Cite This Article
Knight, V.; Merkel, P.A.; O’Sullivan, M.D. Anticytokine Autoantibodies: Association with Infection and Immune Dysregulation. Antibodies 2016, 5, 3.
Knight V, Merkel PA, O’Sullivan MD. Anticytokine Autoantibodies: Association with Infection and Immune Dysregulation. Antibodies. 2016; 5(1):3.Chicago/Turabian Style
Knight, Vijaya; Merkel, Patricia A.; O’Sullivan, Michael D. 2016. "Anticytokine Autoantibodies: Association with Infection and Immune Dysregulation." Antibodies 5, no. 1: 3.
Note that from the first issue of 2016, MDPI journals use article numbers instead of page numbers. See further details here.